Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Basic Science Posters (Oncology)

  • You have access
    Radioiodine therapy oflung cancer following targeting expression of thesodium iodide symporter induced by midkine promoter
    Da Mu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1296;
  • You have access
    PET imaging of gonadotropin releasing hormone receptor expression using [18F]-labeled GnRH peptide
    Kongzhen Hu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1291;
  • You have access
    A boron derived tyrosine mimic identifies cancer with positron emission tomography
    Jiyuan Li, Yuxiang Han, Hui Liu and Zhibo Liu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1259;
  • You have access
    Identifying an appropriate animal model to examine preservation of salivary function with PSMA targeted radiotherapies.
    Jyoti Roy, Blake Warner, Falguni Basuli, Mark Williams, Karen Wong, Anita Ton, John Chiorini, Peter Choyke, Frank Lin and Elaine Jagoda
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1255;
  • You have access
    Activating TiO2 Nanoparticle: Gallium-68 Serves As A High-Yielded Photon Emitter for Cerenkov Induced Photodynamic Therapy
    Dongban Duan, Hui Liu, Yang Xu, Yuxiang Han, Mengxin Xu and Zhibo Liu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1247;
  • You have access
    Preclinical evaluation of 68Ga-pentixafor for PET imaging of CXCR4 expression in lymphoproliferative diseases and solid tumors: a comparison to 18F-FDG PET imaging
    Qingqing Pan, Yaping Luo, Shaobo Yao and Fang Li
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1266;
  • You have access
    Correlation between PD-L1 expression and glucose metabolic indexes of 18F-FDG PET/CT imaging of patients with lung adenocarcinoma.
    Yan Cui, Yaming Li and Xuena Li
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1244;
  • You have access
    Therapeutic delivery of miR-143 targeting tumor metabolism in poorly differentiated thyroid cancer xenografts and efficacy evaluation using 18F-FDG microPET-CT
    Ying Miao and Biao Li
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1250;
  • You have access
    Reassembly of cancer cell membranes into nanovehicles as a PET-trackable carrier for tumor-targeted theranostics
    Bo Yu, Shreya Goel, Dalong NI, Dawei Jiang, Lei Kang, Todd Barnhart and Weibo Cai
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1264;
  • You have access
    Preliminary efficacy evaluation of 64Cu-labeled disintegrin in tracking response to docetaxel treatment in prostate tumor-bearing mice
    Hossein Jadvar, Kai Chen, Ryan Park, Ivetta Vorobyova, Teresa Bui, Steve Swenson and Frank Markland
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1267;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 12
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire